The Type 2 Diabetes Gene Product STARD10 Is a Phosphoinositide Binding Protein That Controls Insulin Secretory Granule Biogenesis
bioRxiv preprint doi: https://doi.org/10.1101/2020.03.25.007286; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The type 2 diabetes gene product STARD10 is a phosphoinositide binding protein that controls insulin secretory granule biogenesis Gaelle R. Carrat1, Elizabeth Haythorne1, Alejandra Tomas1, Leena Haataja2, Andreas Müller3,4,5,6, Peter Arvan2, Alexandra Piunti1,7, Kaiying Cheng8, Mutian Huang1, Timothy J. Pullen1,9, Eleni Georgiadou1, Theodoros Stylianides10, Nur Shabrina Amirruddin11,12, Victoria Salem 1,13, Walter Distaso14, Andrew Cakebread 15, Kate J.Heesom16, Philip A. Lewis16, David J. Hodson17, Linford J. Briant18, Annie C.H. Fung19, Richard B. Sessions20, Fabien Alpy21, Alice P.S. Kong19, Peter I. Benke22, Federico Torta22, Adrian Kee Keong Teo11,12, 23, Isabelle Leclerc1, Michele Solimena 3,4,5,6 , Dale B. Wigley8 and Guy A. Rutter1* 1 - Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London W12 0NN, UK. 2 - Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. 3 - Molecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany. 4 - Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany. 5 - German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
[Show full text]